Federal Register Notice for Hepatitis C Testing Among Perinatally Exposed Infants and Children
The content on this webpage is available for historical purposes. CDC is no longer reviewing or updating this content.
On November 22, 2022, the Centers for Disease Control and Prevention (CDC) published a Federal Register Notice (FRN) #CDC-2022-0116 to obtain comment on proposed perinatal hepatitis C testing recommendations. The recommendations supplement CDC’s 2020 universal hepatitis C screening recommendations by including testing recommendations for perinatally exposed infants and children. Testing exposed infants with a nucleic acid test (NAT) for HCV ribonucleic acid (RNA) at age 2-6 months is expected to identify more perinatally exposed children and increase opportunities for linkage to care and curative treatment.
The Federal Register Notice, docket number CDC-2022-0116, is open for public comment through January 27, 2023.
Learn More about this Federal Register Notice
CDC hosted a webinar on Tuesday, December 6, 2022, at 3:00pm ET, presenting an overview of the proposed recommendations.
Click here to view the webinar slides
Questions?
Send questions about the FRN or how to post a comment to: DVHpolicy@cdc.gov